Correlation Between Aequus Pharmaceuticals and Lobe Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aequus Pharmaceuticals and Lobe Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aequus Pharmaceuticals and Lobe Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aequus Pharmaceuticals and Lobe Sciences, you can compare the effects of market volatilities on Aequus Pharmaceuticals and Lobe Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aequus Pharmaceuticals with a short position of Lobe Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aequus Pharmaceuticals and Lobe Sciences.

Diversification Opportunities for Aequus Pharmaceuticals and Lobe Sciences

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Aequus and Lobe is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Aequus Pharmaceuticals and Lobe Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lobe Sciences and Aequus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aequus Pharmaceuticals are associated (or correlated) with Lobe Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lobe Sciences has no effect on the direction of Aequus Pharmaceuticals i.e., Aequus Pharmaceuticals and Lobe Sciences go up and down completely randomly.

Pair Corralation between Aequus Pharmaceuticals and Lobe Sciences

Assuming the 90 days horizon Aequus Pharmaceuticals is expected to under-perform the Lobe Sciences. But the otc stock apears to be less risky and, when comparing its historical volatility, Aequus Pharmaceuticals is 37.68 times less risky than Lobe Sciences. The otc stock trades about -0.17 of its potential returns per unit of risk. The Lobe Sciences is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest  0.14  in Lobe Sciences on August 29, 2024 and sell it today you would earn a total of  0.74  from holding Lobe Sciences or generate 528.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Aequus Pharmaceuticals  vs.  Lobe Sciences

 Performance 
       Timeline  
Aequus Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aequus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Lobe Sciences 

Risk-Adjusted Performance

28 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Lobe Sciences are ranked lower than 28 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain technical and fundamental indicators, Lobe Sciences reported solid returns over the last few months and may actually be approaching a breakup point.

Aequus Pharmaceuticals and Lobe Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aequus Pharmaceuticals and Lobe Sciences

The main advantage of trading using opposite Aequus Pharmaceuticals and Lobe Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aequus Pharmaceuticals position performs unexpectedly, Lobe Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lobe Sciences will offset losses from the drop in Lobe Sciences' long position.
The idea behind Aequus Pharmaceuticals and Lobe Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data